Recent Publications
- Young K, et al. Among authors: yu j.
J Am Acad Dermatol. 2023 Jan 19:S0190-9622(23)00086-5. doi: 10.1016/j.jaad.2023.01.016. Online ahead of print.
- Smith ER, et al.
BMJ Glob Health. 2023 Jan;8(1):e009495. doi: 10.1136/bmjgh-2022-009495.
Interferon and myeloproliferative neoplasms: Evolving therapeutic approaches.
Swaroop A, Saleiro D, Platanias LC.Bioessays. 2023 Jan 15:e2200203. doi: 10.1002/bies.202200203. Online ahead of print.
The HAPSTR2 retrogene buffers stress signaling and resilience in mammals.
Amici DR, Cingoz H, Alasady MJ, Alhayek S, Phoumyvong CM, Sahni N, Yi SS, Mendillo ML.Nat Commun. 2023 Jan 11;14(1):152. doi: 10.1038/s41467-022-35697-1.
CD95/Fas ligand induced toxicity.
Haluck-Kangas A, Peter ME.Biochem Soc Trans. 2023 Jan 11:BST20211187. doi: 10.1042/BST20211187. Online ahead of print.
GATOR2 rings GATOR1 to speak to mTORC1.
Sahu U, Ben-Sahra I.Mol Cell. 2023 Jan 5;83(1):6-8. doi: 10.1016/j.molcel.2022.12.011.
Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma.
Sasaki T, Watanabe J, He X, Katagi H, Suri A, Ishi Y, Abe K, Natsumeda M, Frey WH, Zhang P, Hashizume R.J Neurosurg. 2022 Nov 11:1-10. doi: 10.3171/2022.9.JNS22715. Online ahead of print.
- Murmann AE, Patel M, Jeong SY, Bartom ET, Jennifer Morton A, Peter ME.
Cell Death Dis. 2022 Dec 30;13(12):1078. doi: 10.1038/s41419-022-05494-1.
Role of Biomarkers in the Management of Acute Myeloid Leukemia.
Small S, Oh TS, Platanias LC.Int J Mol Sci. 2022 Nov 22;23(23):14543. doi: 10.3390/ijms232314543.
- Jin Q, et al. Among authors: crispino jd, goo ya, ntziachristos p, ben sahra i.
Sci Adv. 2022 Dec 9;8(49):eabq8437. doi: 10.1126/sciadv.abq8437. Epub 2022 Dec 9.